Literature DB >> 6293974

Epidemiological aspects of acute viral hepatitis in drug abusers.

F Bortolotti, A Bertaggia, P Cadrobbi, C Crivellaro, E Pornaro, G Realdi.   

Abstract

The epidemiological features of acute symptomatic viral hepatitis were examined in 151 consecutive, hospitalized drug abusers. Hepatitis B was diagnosed in 101 patients (66.8%), hepatitis A in 13 (8.6%) and non-A, non-B hepatitis in 35 (23.1%). Non-A, non-B hepatitis was significantly more prevalent among drug abusers than in an age-matched control population of non-drug abusers. Moreover, the mean duration of parenteral drug abuse was significantly lower among non-A, non-B cases than in patients with hepatitis A or B. These results suggest a wide circulation of both hepatitis B virus and non-A, non-B agent(s) among drug abusers in our area. These patients most likely represent a main reservoir of non-A, non-B infection due to the high rate of chronicity reported for non-A, non-B hepatitis.

Entities:  

Mesh:

Year:  1982        PMID: 6293974     DOI: 10.1007/bf01640873

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  15 in total

1.  Etiology of sporadic hepatitis B surface antigen-negative hepatitis.

Authors:  J L Dienstag; A Alaama; J W Mosley; A G Redeker; R H Purcell
Journal:  Ann Intern Med       Date:  1977-07       Impact factor: 25.391

2.  Medical disorders in drug addicts. 200 consecutive admissions.

Authors:  A G White
Journal:  JAMA       Date:  1973-03-26       Impact factor: 56.272

3.  Multiple attacks of hepatitis in drug addicts: biochemical, immunochemical, and morphologic characteristics.

Authors:  S Iwarson; P Lundin; J Holmgren; S Hermodsson
Journal:  J Infect Dis       Date:  1973-05       Impact factor: 5.226

4.  Impact of illicit drug-associated hepatitis on viral hepatitis morbidity reports in the United States.

Authors:  R A Garibaldi; B Hanson; M B Gregg
Journal:  J Infect Dis       Date:  1972-09       Impact factor: 5.226

5.  Non-A, non-B hepatitis in Milan.

Authors:  F Caredda; A d'Arminio Monforte; E Rossi; S Lopez; M Moroni
Journal:  Lancet       Date:  1981-07-04       Impact factor: 79.321

6.  Hepatic disease in asymptomatic parenteral narcotic drug abusers: a Veterans Administration collaborative study.

Authors:  L B Seeff; H J Zimmerman; E C Wright; E R Schiff; T Kiernan; C M Leevy; C H Tamburro; K G Ishak
Journal:  Am J Med Sci       Date:  1975 Jul-Aug       Impact factor: 2.378

7.  The epidemiological pattern of hepatitis A, B, and non-A, non-B in Sweden.

Authors:  G Norkrans; G Frösner; S Hermodsson; N Nenonen; S Iwarson
Journal:  Scand J Gastroenterol       Date:  1978       Impact factor: 2.423

8.  Trends in intravenous drug abuse as reflected in national hepatitis reporting.

Authors:  L Minichiello; R Retka
Journal:  Am J Public Health       Date:  1976-09       Impact factor: 9.308

9.  Serodiagnosis of viral hepatitis A: detection of acute-phase immunoglobulin M anti-hepatitis A virus by radioimmunoassay.

Authors:  D W Bradley; J E Maynard; S H Hindman; C L Hornbeck; H A Fields; K A McCaustland; E H Cook
Journal:  J Clin Microbiol       Date:  1977-05       Impact factor: 5.948

10.  Multiple hepatitis attacks in drug addicts.

Authors:  G Norkrans; G Frösner; S Hermodsson; S Iwarson
Journal:  JAMA       Date:  1980-03-14       Impact factor: 56.272

View more
  7 in total

1.  The changing epidemiology of acute type B hepatitis: results of an 11-year prospective study in Padua (northern Italy).

Authors:  F Bortolotti; P Cadrobbi; C Crivellaro; F Menenghetti; M Carretta; A Stivanello; A De Rossi; F Noventa
Journal:  Infection       Date:  1989 Nov-Dec       Impact factor: 3.553

Review 2.  Non-A, non-B hepatitis: dead ends or new horizons?

Authors:  S A Iwarson
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-17

3.  Epidemiology of hepatitis A in northern Italy: a seven-year survey.

Authors:  M Armigliato; F Bortolotti; A Bertaggia; M Carretta; F Meneghetti; F Noventa; G Realdi
Journal:  Infection       Date:  1986 Nov-Dec       Impact factor: 3.553

4.  Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program.

Authors:  H Hagan; D C Jarlais; S R Friedman; D Purchase; M J Alter
Journal:  Am J Public Health       Date:  1995-11       Impact factor: 9.308

5.  Hepatitis C virus (HCV) genotypes in 373 Italian children with HCV infection: changing distribution and correlation with clinical features and outcome.

Authors:  F Bortolotti; M Resti; M Marcellini; R Giacchino; G Verucchi; G Nebbia; L Zancan; M G Marazzi; C Barbera; A Maccabruni; G Zuin; G Maggiore; F Balli; P Vajro; L Lepore; M Molesini; M Guido; S Bartolacci; F Noventa
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

6.  Hepatitis C virus infection in patients with acute hepatitis B.

Authors:  M Rodríguez; C A Navascués; A Martínez; A Suárez; N G Sotorrío; R Cimadevilla; A Linares; R Pérez; L Rodrigo
Journal:  Infection       Date:  1992 Nov-Dec       Impact factor: 3.553

7.  Chronic evolution of acute hepatitis type B: prevalence and predictive markers.

Authors:  F Bortolotti; A Bertaggia; C Crivellaro; M Armigliato; A Alberti; P Pontisso; C Chemello; G Realdi
Journal:  Infection       Date:  1986 Mar-Apr       Impact factor: 3.553

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.